RecruitingNCT03916302

Pulmonary Embolism WArsaw REgistry


Sponsor

Medical University of Warsaw

Enrollment

1,500 participants

Start Date

Jan 1, 2008

Study Type

OBSERVATIONAL

Conditions

Summary

Initiated in January 2008, The PE-aWARE (Pulmonary Embolism WArsaw REgistry) is an on-going single-centre prospective observational study of patients with confirmed acute pulmonary embolism (APE). Extensive data on consecutive patients with pulmonary embolism is collected and stored. The main objective is to collect and provide information on patients' characteristics, management, and outcome with the purpose of decreasing mortality in APE, the occurrence of bleeding, and the frequency of thromboembolic recurrences. Moreover, the PE-aWARE registry serves as a basis for creating predictive scores for clinicians which aid patient management. The study endpoints comprise clinically recognized (and objectively confirmed) recurrences of PE, major and minor bleeding complications classified according to the International Society on Thrombosis and Haemostasis classification, need for cardiopulmonary resuscitation or catecholamines, and death.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • objectively confirmed pulmonary embolism
  • Informed consent for the participation in the study, according to the requirements of the ethics committee

Exclusion Criteria1

  • lack of consent

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Department of Internal Medicine & Cardiology with the Centre for Management of Venous Thromboembolic Disease, Medical University of Warsaw

Warsaw, Poland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03916302


Related Trials